Lv1
30 积分 2022-07-23 加入
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
2天前
已完结
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
9天前
已完结
Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data
9天前
已完结
Biomarkers of ageing of humans and non-human primates
12天前
已完结
Health effects associated with consumption of processed meat, sugar-sweetened beverages and trans fatty acids: a Burden of Proof study
14天前
已完结
Novel use of abatacept and ruxolitinib as salvage therapy in steroid-refractory immune checkpoint blockade-induced myocarditis with myasthenia and myositis overlap syndrome
18天前
已完结
Clinical Issue of Myasthenia Gravis Related to Immune Checkpoint Inhibitors
18天前
已完结
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
20天前
已完结
Artificial intelligence in drug development
24天前
已完结
皖公网安备34019202002308
